v3.25.1
Condensed Consolidated Statements of Non-Convertible Preferred Stock, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Non-Convertible Preferred Stock
Redeemable Convertible Preferred Stock
Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Temporary equity, Beginning balance (in shares) at Jan. 31, 2024   250,000 42,465,855          
Temporary equity, Beginning balance at Jan. 31, 2024   $ 233,546 $ 1,395,878          
Beginning balance (in shares) at Jan. 31, 2024       34,185,388        
Beginning balance at Jan. 31, 2024 $ (477,863)     $ 34     $ 388,739 $ (866,636)
Issuance of common stock, acquisition consideration (in shares)       378,711        
Issuance of common stock, acquisition consideration 23,822     $ 1     23,821  
Temporary Equity, Accretion of non-convertible preferred stock 12,987 $ 12,987            
Accretion of non-convertible preferred stock (12,987)           (12,987)  
Exercise of stock options (in shares)       126,955        
Exercise of stock options 1,440           1,440  
Settlement of restricted stock units (in shares)       231,446        
Shares repurchased for tax withholding on settlement of restricted stock units (in shares)       (85,331)        
Shares repurchased for tax withholding on settlement of restricted stock units (5,306)           (5,306)  
Reclassification from liabilities upon vesting of early exercised stock options 69           69  
Stock-based compensation 20,899           20,899  
Net loss (56,039)             (56,039)
Ending balance (in shares) at Apr. 30, 2024       34,837,169        
Ending balance at Apr. 30, 2024 (505,965)     $ 35     416,675 (922,675)
Temporary equity, Ending balance (in shares) at Apr. 30, 2024   250,000 42,465,855          
Temporary equity, Ending balance at Apr. 30, 2024   $ 246,533 $ 1,395,878          
Beginning balance (in shares) at Jan. 31, 2025         76,644,240 13,404,097    
Beginning balance at Jan. 31, 2025 1,454,584       $ 77 $ 13 2,560,224 (1,105,730)
Initial public offering costs incurred (150)           (150)  
Shares cancelled related to previously issued RSAs (in shares)         (280)      
Temporary Equity, Accretion of non-convertible preferred stock 0              
Exercise of stock options (in shares)         107,288      
Exercise of stock options 1,181           1,181  
Settlement of restricted stock units (in shares)         485,434      
Settlement of restricted stock units 1       $ 1      
Shares repurchased for tax withholding on settlement of restricted stock units (in shares)         (12)      
Reclassification from liabilities upon vesting of early exercised stock options 30           30  
Stock-based compensation 44,647           44,647  
Net loss (46,364)             (46,364)
Ending balance (in shares) at Apr. 30, 2025         77,236,670 13,404,097    
Ending balance at Apr. 30, 2025 $ 1,453,929       $ 78 $ 13 $ 2,605,932 $ (1,152,094)